Don’t miss the latest developments in business and finance.

F&O expiry may cap gains

TECHNICALS

Image
Vijay Bhambwani Mumbai
Last Updated : Feb 14 2013 | 7:29 PM IST
The markets opened on a bullish note and proceeded to end the day on a somber note. The benchmark indices closed off their intra-day perches as profit-sales shaved off gains of the initial part of the session.
 
The traded volumes were higher than the previous session as a higher intra-day churn was evident.
 
The market breadth was marginally negative as the BSE and NSE combined figures were 1,518 : 1,864 and the capitalisation of the breadth was positive as the figures on a BSE and NSE combined basis were Rs 9,643 crore : Rs 5,841 crore.
 
The F&O data of the previous session points towards a paring of exposure by 0.80 per cent on a net basis as the bulls showed a bias towards unloading positions at higher levels.
 
The indices have shown a weak pattern on the daily charts with the banking, midcap and technology indices actually showing bar reversals as the closing was clearly lower than the opening and the intra-day highs were significantly higher than the current upmoves.
 
The traded volumes being higher on such a key reversal day is not welcome news for the markets. As indicated yesterday, upsides have indeed met with selling pressure in the markets and the 3,574.44-resistance level specified has not been surpassed.
 
The outlook for the markets on Thursday is that of caution as the upsides are likely to witness some more paring of exposure as the impeding expiry of the April F&O series coupled with profit-taking by short term players is likely to cap gains in the absolute short term.
 
Sectoral strength maybe seen in the pharmaceutical scrips as investors are showing a bias towards "flight to quality," as the turbulence in the market steps up. Aggressive purchases, bottom-fishing and averaging is ruled out for now.

Vijay L. Bhambwani
(CEO- BSPLindia.com)

The author is a Mumbai based investment consultant and invites feedback at vijay@BSPLindia.com  or ( 022 ) 23438482 / 23400345.
 
SEBI disclosure: the analyst has no exposure to the scrips mentioned above.

 
 

Also Read

First Published: Apr 20 2006 | 12:00 AM IST

Next Story